AlloVir Inc (ALVR)
0.807
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
0.8062
0.00 (0.00%)
After-Hours: 20:00
AlloVir 1 Year Total Returns (Daily): -78.31% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -78.31% |
May 01, 2024 | -78.23% |
April 30, 2024 | -76.91% |
April 29, 2024 | -76.32% |
April 26, 2024 | -77.36% |
April 25, 2024 | -77.01% |
April 24, 2024 | -78.75% |
April 23, 2024 | -79.46% |
April 22, 2024 | -80.18% |
April 19, 2024 | -80.51% |
April 18, 2024 | -81.02% |
April 17, 2024 | -81.43% |
April 16, 2024 | -81.06% |
April 15, 2024 | -80.77% |
April 12, 2024 | -78.40% |
April 11, 2024 | -79.12% |
April 10, 2024 | -80.08% |
April 09, 2024 | -80.42% |
April 08, 2024 | -80.61% |
April 05, 2024 | -79.70% |
April 04, 2024 | -80.01% |
April 03, 2024 | -80.32% |
April 02, 2024 | -80.52% |
April 01, 2024 | -79.57% |
March 28, 2024 | -81.17% |
Date | Value |
---|---|
March 27, 2024 | -81.91% |
March 26, 2024 | -81.62% |
March 25, 2024 | -81.36% |
March 22, 2024 | -81.89% |
March 21, 2024 | -84.20% |
March 20, 2024 | -83.62% |
March 19, 2024 | -83.60% |
March 18, 2024 | -83.91% |
March 15, 2024 | -84.51% |
March 14, 2024 | -85.41% |
March 13, 2024 | -84.50% |
March 12, 2024 | -84.80% |
March 11, 2024 | -85.12% |
March 08, 2024 | -86.29% |
March 07, 2024 | -87.49% |
March 06, 2024 | -87.83% |
March 05, 2024 | -88.08% |
March 04, 2024 | -87.95% |
March 01, 2024 | -88.05% |
February 29, 2024 | -89.09% |
February 28, 2024 | -89.42% |
February 27, 2024 | -89.00% |
February 26, 2024 | -89.25% |
February 23, 2024 | -90.10% |
February 22, 2024 | -89.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.10%
Minimum
Feb 23 2024
60.00%
Maximum
Jun 13 2023
-56.36%
Average
-64.79%
Median
1 Year Total Returns (Daily) Benchmarks
Arcutis Biotherapeutics Inc | -39.48% |
CEL-SCI Corp | -37.82% |
AIM ImmunoTech Inc | -16.66% |
IGC Pharma Inc | 51.16% |
NovaBay Pharmaceuticals Inc | -91.96% |